Literature DB >> 20848811

New Delhi Metallo-beta lactamase (NDM-1) in Enterobacteriaceae: treatment options with carbapenems compromised.

Payal Deshpande1, Camilla Rodrigues, Anjali Shetty, Farhad Kapadia, Ashit Hedge, Rajeev Soman.   

Abstract

BACKGROUND: Carbapenems are among the few useful antibiotics against multidrug resistant gram negative bacteria particularly those with extended spectrum beta lactamase. However resistance to carbapenems occurs and is mediated by mechanisms like loss of outer membrane proteins and production of beta lactamase that is capable of hydrolyzing carbapenems. An alert issued in the UK in 2009 warned of an increasing number of carbapenem resistant Enterobacteriaceae strains identified in UK hospital patients. Many of them were recently hospitalized in India and Pakistan and had new type of metallo beta lactamase designated as New Delhi Metallo-1 (NDM-1).
OBJECTIVE: To assess the production of NDM-1 type Metallo beta lactamase enzyme in Enterobacteriaceae at a tertiary care centre in Mumbai.
MATERIALS AND METHODS: Consecutive carbapenem resistant Enterobacteriaceae isolates were collected from August 2009 to November 2009. Susceptibility testing for carbapenems was performed by the disc diffusion method. Carbapenemase production was confirmed by Modified Hodge test. These strains were then subjected to single target PCR. A 475bp product was amplified by the NDM primers and visualized on 3% agarose gel. RESULTS AND
CONCLUSIONS: Modified Hodge test was positive for all carbapenem resistant isolates. Of 24 carbapenem resistant Enterobacteriaceae 22 were NDM producers while 2 were NDM non producers. Amongst the 22 NDM producing organisms 10 were Klebsiella spp, 9 were Escherichia coli, 2 were Enterobacter spp and 1 was Morganella morganii. This high number in a relatively short span is a worrisome trend that compromises the treatment options with the carbapenems.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20848811

Source DB:  PubMed          Journal:  J Assoc Physicians India        ISSN: 0004-5772


  54 in total

1.  NDM-1 and the Role of Travel in Its Dissemination.

Authors:  Mary Elizabeth Wilson; Lin H Chen
Journal:  Curr Infect Dis Rep       Date:  2012-06       Impact factor: 3.725

Review 2.  How to detect NDM-1 producers.

Authors:  Patrice Nordmann; Laurent Poirel; Amélie Carrër; Mark A Toleman; Timothy R Walsh
Journal:  J Clin Microbiol       Date:  2010-12-01       Impact factor: 5.948

3.  A comparative analysis of how the media in the United Kingdom and India represented the emergence of NDM-1.

Authors:  Vanessa Saliba; Peter Washer; Philippa Pett; Manish Kakkar; Syed Abbas; Bhavna Raghuvanshi; Martin McKee
Journal:  J Public Health Policy       Date:  2015-10-01       Impact factor: 2.222

4.  Increasing prevalence and dissemination of NDM-1 metallo-β-lactamase in India: data from the SMART study (2009).

Authors:  Christine Lascols; Meredith Hackel; Steven H Marshall; Andrea M Hujer; Sam Bouchillon; Robert Badal; Daryl Hoban; Robert A Bonomo
Journal:  J Antimicrob Chemother       Date:  2011-06-14       Impact factor: 5.790

Review 5.  New Delhi metallo-β-lactamase-1 in Enterobacteriaceae: emerging resistance.

Authors:  Dylan R Pillai; Allison McGeer; Donald E Low
Journal:  CMAJ       Date:  2011-01-11       Impact factor: 8.262

6.  New Delhi metallo-β-lactamase-1: detection and prevention.

Authors:  Timothy R Walsh
Journal:  CMAJ       Date:  2011-07-25       Impact factor: 8.262

7.  Early detection of colonization by VIM-1-producing Klebsiella pneumoniae and NDM-1-producing Escherichia coli in two children returning to France.

Authors:  André Birgy; Catherine Doit; Patricia Mariani-Kurkdjian; Nathalie Genel; Albert Faye; Guillaume Arlet; Edouard Bingen
Journal:  J Clin Microbiol       Date:  2011-06-08       Impact factor: 5.948

8.  Molecular characterization of carbapenem-resistant Enterobacteriaceae at a tertiary care laboratory in Mumbai.

Authors:  M Kazi; L Drego; C Nikam; K Ajbani; R Soman; A Shetty; C Rodrigues
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-09-27       Impact factor: 3.267

9.  Ten major priorities for intensive care in India.

Authors:  J V Divatia; Shivakumar Iyer
Journal:  Intensive Care Med       Date:  2015-01-09       Impact factor: 17.440

10.  Study on MICs of Tigecycline in Clinical Isolates of Carbapenem Resistant Enterobacteriaceae (CRE) at a Tertiary Care Centre in North India.

Authors:  Vineeta Khare; Prashant Gupta; Fareya Haider; Rehana Begum
Journal:  J Clin Diagn Res       Date:  2017-03-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.